An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
about
Hepatitis C genotype 6: A concise review and response-guided therapy proposalPeginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis CHepatitis C virus protease inhibitor-resistance mutations: our experience and reviewRole of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infectionConceptual framework for outcomes research studies of hepatitis C: an analytical reviewInterferon Lambda 4 Polymorphism Predicts Sustained Viral Response in Hepatitis C Virus Patients Irrespective of Hepatitis C Virus Genotypes, Ethnicity or Treatment Regimen: Results From a Meta-AnalysisChronic hepatitis C: This and the new era of treatmentClinical Advances in Fibrosis Progression of Chronic Hepatitis B and CImpact of new treatment options for hepatitis C virus infection in liver transplantationHepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antiviralsManagement of chronic hepatitis C virus infection in patients with end-stage renal disease: a reviewMaximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virusNew hepatitis C virus drug discovery strategies and model systemsAntiviral treatment of hepatitis C virus infection and factors affecting efficacyEmerging therapies for hepatitis CUpdate on the treatment of patients with non-genotype 1 hepatitis C virus infectionBarriers to hepatitis C treatmentThe place of immunotherapy in the management of HCV-induced vasculitis: an updateNew virologic tools for management of chronic hepatitis B and CMagnetic resonance elastography of liver: technique, analysis, and clinical applications.The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease InhibitorsThe relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1.Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.The Daniel K. Inouye College of Pharmacy Scripts: Hepatitis C in 2015: Recent Advancements and Current ChallengesDrug-Drug Interactions with the NS3/4A Protease Inhibitor SimeprevirAutoantibodies in chronic hepatitis C: A clinical perspectiveHCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitorsHigh-throughput screening (HTS) and hit validation to identify small molecule inhibitors with activity against NS3/4A proteases from multiple hepatitis C virus genotypesFeasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 resultsNew preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replicationHepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infectionGenetic characterization of hepatitis C virus in long-term RNA replication using Li23 cell culture systemsUltrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome PredictorsChanging Epidemiology of Hepatitis C Virus Genotype among Patients with Human Immunodeficiency Virus/Hepatitis C Virus Co-Infection in ChinaExploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replicationResults of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C.Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.Magnetic resonance elastography of liver: clinical applications.Noninvasive diagnosis of cirrhosis: a review of different imaging modalities.An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver.
P2860
Q22305417-A9E07FA1-3772-4B9F-8B3A-335D8C4C7544Q24200197-AEAA9BCC-E68B-487D-B983-2D78DC2AB348Q24628717-BC8C4342-67E1-4BB7-AD23-FD1E23637C0CQ26740216-1A5AC280-85FC-4616-88C1-A2732B63E502Q26745582-BEED94FC-4493-4A12-8FEF-F02468033871Q26765752-439106DD-0DCF-49D3-A8BD-4F2F073DEC33Q26775011-AA2CDFA2-142C-42D5-85B7-641B3D466F4FQ26781789-274D2F1B-78AC-4EC2-94CD-DB1394FF86A5Q26782017-73420564-4ED6-4065-8F74-553A5DB501B8Q26782033-EB8EAA6E-309C-4D27-BF3D-E32E79AF6DD0Q26821786-52B74EDA-95E2-4896-AE94-FA4BCC41A631Q26830190-08935AAC-D452-4B33-949C-D1EF39109906Q26851159-2E6F4A33-59BD-4E0E-B402-1849F50EDA6AQ26851810-8B64DA42-A874-4C04-9AB1-5DD144D7AF77Q26853642-8323BCCC-6018-4BA1-86A2-D1AEC82D79ECQ27000806-C190DC2A-F1B4-44DF-A04B-EEA42C85FB6FQ27012664-7C98CF71-7643-463F-8E95-7D23002EF453Q27015124-103B62FA-71CA-4B16-B3DD-B1C30CA23F0DQ27026914-5E3C2812-903E-478D-B3A5-193DC504104EQ27027849-1CF52E86-6777-4034-A97F-E22506C99999Q27671640-F10EC0C3-AE4F-4917-876C-21F37E1ABFFEQ27690869-537F0118-1186-4140-80BF-AC504FFB5DD8Q27692609-39BB73BF-73A6-4DBC-994F-13323E8F6C52Q28081108-537A3F7A-FDCA-4240-842D-F75B6F2E3A04Q28084266-3A7C6C9E-AD11-45C1-8506-9CF99BEF8E7FQ28088556-122A3FEA-227F-4AFD-9AD0-CB038CF6BB9BQ28481038-AD85135E-2A04-4D91-8862-D3C2473251C7Q28534286-1E559182-5A93-4002-A68C-776E90C6DEBBQ28535042-83EAAE7D-5987-4768-B294-6D377F39EE78Q28536288-C3683661-9808-4F41-BBC7-2E89339821CDQ28537754-88577AAE-6FDC-4E26-9196-DC7AB5CDF288Q28540849-81D1F93B-1C06-4BE1-A4EC-9FF8A7E2BE46Q28553721-7DAA6028-C2EB-4797-9632-E351C62F6BA9Q28553922-FC33AEA2-9E4B-4ADC-9846-ED31C5FCFF9AQ28830384-AC3428E0-8182-45EF-85CD-BCCCD31E3E0CQ30151392-1552E15F-663C-4994-B38B-9029A524F12BQ30151690-82973D66-2C33-4B39-A4A7-C37B8D48C829Q30435917-2B79E04D-AB11-4B50-B918-610DB9C83ED6Q30436164-B960EFB4-D988-4A54-AC82-76D0023C68F6Q30453975-25A45E4A-B593-4902-B4DC-F713B3C4AB27
P2860
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
An update on treatment of geno ...... or the Study of Liver Diseases
@ast
An update on treatment of geno ...... or the Study of Liver Diseases
@en
An update on treatment of geno ...... or the Study of Liver Diseases
@nl
type
label
An update on treatment of geno ...... or the Study of Liver Diseases
@ast
An update on treatment of geno ...... or the Study of Liver Diseases
@en
An update on treatment of geno ...... or the Study of Liver Diseases
@nl
prefLabel
An update on treatment of geno ...... or the Study of Liver Diseases
@ast
An update on treatment of geno ...... or the Study of Liver Diseases
@en
An update on treatment of geno ...... or the Study of Liver Diseases
@nl
P2093
P2860
P3181
P356
P1433
P1476
An update on treatment of geno ...... or the Study of Liver Diseases
@en
P2093
David L Thomas
David R Nelson
Doris B Strader
Leonard B Seeff
Marc G Ghany
P2860
P304
P3181
P356
10.1002/HEP.24641
P407
P577
2011-10-01T00:00:00Z